LeMaitre Vascular, Inc. Share Price
Equities
LMAT
US5255582018
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.50 USD | +1.22% |
|
+1.72% | +6.66% |
| 11-07 | Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 27, 2025. | CI |
| 11-07 | LeMaitre Vascular, Inc., Q3 2025 Earnings Call, Nov 06, 2025 |
| Capitalization | 1.96B 1.69B 1.58B 1.47B 2.73B 177B 2.92B 18.1B 7.12B 84.76B 7.36B 7.21B 311B | P/E ratio 2025 * |
35.3x | P/E ratio 2026 * | 33.5x |
|---|---|---|---|---|---|
| Enterprise value | 1.96B 1.69B 1.58B 1.47B 2.73B 177B 2.92B 18.1B 7.12B 84.76B 7.36B 7.21B 311B | EV / Sales 2025 * |
7.9x | EV / Sales 2026 * | 7.25x |
| Free-Float |
85.13% | Yield 2025 * |
0.92% | Yield 2026 * | 0.92% |
Last Transcript: LeMaitre Vascular, Inc.
| 1 day | +1.22% | ||
| 1 week | +1.72% | ||
| Current month | +6.66% | ||
| 1 month | +4.51% | ||
| 3 months | -0.87% | ||
| 6 months | +5.19% | ||
| Current year | +6.66% |
| 1 week | 81.88 |  | 87.72 |
| 1 month | 79.4 | | 88.28 |
| Current year | 79.4 | | 87.72 |
| 1 year | 71.42 | | 105.55 |
| 3 years | 44.27 | | 109.58 |
| 5 years | 38.32 | | 109.58 |
| 10 years | 12.03 | | 109.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
George LeMaitre
CEO | Chief Executive Officer | 61 | 31/05/1992 |
David Roberts
DFI | Director of Finance/CFO | 62 | 31/12/1999 |
Dorian LeBlanc
DFI | Director of Finance/CFO | 51 | 09/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
John Roush
BRD | Director/Board Member | 61 | 08/04/2014 |
| Director/Board Member | 61 | 23/10/2016 | |
John O'Connor
BRD | Director/Board Member | 78 | 16/09/2008 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +5.71% | 0.45% | 29 M€ | |
| +5.33% | 0.26% | 22 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.22% | +1.72% | -11.52% | +87.51% | 1.96B | |
| +0.45% | +2.99% | +13.27% | +6.99% | 235B | |
| -0.99% | -7.48% | -6.68% | +109.09% | 192B | |
| +0.82% | +2.08% | +0.81% | -12.33% | 169B | |
| -3.96% | -8.49% | -7.08% | +93.49% | 133B | |
| +0.29% | +0.75% | -8.12% | -6.69% | 60.62B | |
| +1.67% | -0.11% | +20.22% | +7.89% | 49.03B | |
| -0.75% | -0.64% | +1.83% | -7.70% | 41.06B | |
| -3.27% | -6.41% | -1.37% | +26.08% | 37.59B | |
| +0.46% | +3.90% | +11.71% | +19.53% | 37.97B | |
| Average | -0.49% | -1.19% | +1.31% | +32.39% | 95.77B | |
| Weighted average by Cap. | -0.68% | -1.67% | +2.05% | +36.05% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 248M 214M 199M 185M 345M 22.43B 370M 2.29B 901M 10.72B 931M 912M 39.34B | 271M 233M 217M 202M 376M 24.46B 404M 2.5B 983M 11.7B 1.02B 995M 42.91B |
| Net income | 56.85M 48.97M 45.64M 42.46M 78.98M 5.14B 84.73M 524M 206M 2.46B 213M 209M 9.01B | 61.25M 52.76M 49.17M 45.75M 85.1M 5.53B 91.29M 565M 222M 2.65B 230M 225M 9.71B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/01/26 | 86.50 $ | +1.22% | 154,496 |
| 14/01/26 | 85.46 $ | +2.54% | 115,270 |
| 13/01/26 | 83.34 $ | -0.58% | 116,472 |
| 12/01/26 | 83.83 $ | -1.38% | 159,464 |
| 09/01/26 | 85.00 $ | -0.05% | 234,252 |
Delayed Quote Nasdaq, January 15, 2026 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LMAT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition